The Examination of Safety and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
Condition: Fibrodysplasia Ossificans Progressiva Interventions: Drug: Garetosmab; Drug: Placebo Sponsor: Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Fibrodysplasia Ossificans Progressiva | Research